BCNU, cyclophosphamide, and prednisone (BCP) vs. melphalan and prednisone (MP) in myeloma
Publication
, Journal Article
Cohen, HJ; Abramson, N; Bartolucci, A; Bailar, J
Published in: Proceedings of the American Association for Cancer Research
January 1, 1976
Duke Scholars
Published In
Proceedings of the American Association for Cancer Research
Publication Date
January 1, 1976
Volume
Vol.17
Citation
APA
Chicago
ICMJE
MLA
NLM
Cohen, H. J., Abramson, N., Bartolucci, A., & Bailar, J. (1976). BCNU, cyclophosphamide, and prednisone (BCP) vs. melphalan and prednisone (MP) in myeloma. Proceedings of the American Association for Cancer Research, Vol.17.
Cohen, H. J., N. Abramson, A. Bartolucci, and J. Bailar. “BCNU, cyclophosphamide, and prednisone (BCP) vs. melphalan and prednisone (MP) in myeloma.” Proceedings of the American Association for Cancer Research Vol.17 (January 1, 1976).
Cohen HJ, Abramson N, Bartolucci A, Bailar J. BCNU, cyclophosphamide, and prednisone (BCP) vs. melphalan and prednisone (MP) in myeloma. Proceedings of the American Association for Cancer Research. 1976 Jan 1;Vol.17.
Cohen, H. J., et al. “BCNU, cyclophosphamide, and prednisone (BCP) vs. melphalan and prednisone (MP) in myeloma.” Proceedings of the American Association for Cancer Research, vol. Vol.17, Jan. 1976.
Cohen HJ, Abramson N, Bartolucci A, Bailar J. BCNU, cyclophosphamide, and prednisone (BCP) vs. melphalan and prednisone (MP) in myeloma. Proceedings of the American Association for Cancer Research. 1976 Jan 1;Vol.17.
Published In
Proceedings of the American Association for Cancer Research
Publication Date
January 1, 1976
Volume
Vol.17